• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

SR-4835 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759132

SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99nM, Kd=98nM; CDK13: Kd=4.9nM), which disables triple-negative breast cancer (TNBC) cells More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
SR-4835, Inhibitor
Full Product Name
SR-4835
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
100.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
499.36
Solubility
DMSO: 5mg/mL (10.01mM) ultrasonic and warming and heat to 60 degree C
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C21H20Cl2N10O
SMILES
Cn1cc(cn1)-n1cnc2c(NCc3nc4cc(Cl)c(Cl)cc4[nH]3)nc(nc12)N1CCOCC1
CAS Number
2387704-62-1
Target & IC50
CDK12: ic50 98nM (Kd)
CDK13: ic50 4.9nM (Kd)

Product Categories/Family for SR-4835, inhibitor

Structure of SR-4835, inhibitor

SR-4835 Inhibitor – Cat# MBS5759132

Product References and Citations for SR-4835, inhibitor

Quereda V, et al. Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer. Cancer Cell. 2019 Oct 8. pii: S1535-6108(19)30424-6.
Quereda V, et al. Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer. Cancer Cell. 2019 Oct 8. pii: S1535-6108(19)30424-6.
Quereda V Bayle S,et al.CDK12/13 Inhibitor SR-4835 Is Active in Triple-Negative Breast Cancer.Cancer Discov. 2019 Dec;9(12):1644
Quereda V Bayle S,et al.CDK12/13 Inhibitor SR-4835 Is Active in Triple-Negative Breast Cancer.Cancer Discov. 2019 Dec;9(12):1644

Other Notes

Small volumes of SR-4835, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for SR-4835 purchase

MBS5759132 is an inhibitor targeting SR-4835.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000